Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

IBCL-176: Single-Centre Experience with Stem-Cell Transplantation in Patients with Transformed Lymphoma: A Potential Curative Option

Autor: Bua, Beatriz Rey, Santos, Marta Fonseca, Melchor, Raúl Azibeiro, Molano, Luz Gema Román, Mendoza, Danylo Palomino, Muñoz, Andres Felipe Peña, Úbeda, Sandra Patricia Gomez, Martinez, Borja Puertas, Sánchez, Alberto Hernández, Garcia, Laura Prieto, López, Estefania Pérez, Corral, Lucía López, Rodriguez, Maria Cortés, Sánchez-Guijo, Fermín, López, Ana Africa Martín, González, Mónica Baile, Parra, Miriam López, Alcoceba, Miguel, Alonso, Pilar Tamayo, Múñez, Óscar Blanco, Gutiérrez, Norma Carmen Gutiérrez, López, Lourdes Vazquez, Calvo, Mónica Cabrero, Barrigón, María Dolores Caballero, García-Sancho, Alejandro Martín

Publikováno v: In Clinical Lymphoma, Myeloma and Leukemia September 2020 20 Supplement 1:S278-S279

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance.

Autor: Sobas MA; Department of Hematology, Blood Neoplasm and Bone Marrow Transplantation, Wroclaw Medical University., Turki AT; Department of Hematology and Oncology, Marienhospital University Hospital, Ruhr-University Bochum, Bochum., Ramiro AV; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca., Hernández-Sánchez A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca, Spain; Hematology Department, University Hospital of Salamanca, Salamanca., Elicegui JM; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca., González T; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca., Melchor RA; Hematology Department, University Hospital of Salamanca, Salamanca., Abáigar M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca., Tur L; GMV Innovating Solutions, Valencia., Dall'Olio D; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia., Sträng E; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin., Tettero JM; Department of Hematology, Amsterdam University Medical Center location Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Castellani G; Department of Medical and Surgical Sciences - DIMEC, University of Bologna, Bologna., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg., Döhner K; Department of Internal Medicine III, University Hospital Ulm, Ulm., Thiede C; Department of Internal Medicine I, University Hospital Dresden, Dresden., Metzeler KH; Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig., Haferlach T; MLL Munich Leukemia Laboratory, Munich., Damm F; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg., Ayala R; Hematology Department, Hospital Universitario 12 de Octubre, Complutense University CNIO Madrid., Martínez-López J; Hematology Department, Hospital Universitario 12 de Octubre, Complutense University CNIO Madrid., Mills KI; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Sierra J; Hospital Santa Creu Sant Pau, Barcelona., Lehmann S; Uppsala University Hospital, Uppsala., Porta MGD; IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Rozzano, Milan, Italy; and Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Milan., Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University., Reinhardt D; Department of Pediatrics III, University Hospital Essen, University Duisburg-Essen, Essen., Medina RV; GMV Innovating Solutions, Valencia., Schulze-Rath R; Bayer AG, Pharmaceuticals Division, Berlin., Barbus M; AbbVie Deutschland GmbH and Co KG, Wiesbaden., Hernández-Rivas JM; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Hematology Department, University Hospital of Salamanca, Salamanca., Huntly BJP; Department of Haematology and Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge., Ossenkoppele G; Center, Amsterdam UMC,location VUMC, Netherlands., Döhner H; Department of Internal Medicine III, University Hospital Ulm, Ulm., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg. lars.bullinger@charite.de.

Publikováno v: Haematologica [Haematologica] 2024 Nov 07. Date of Electronic Publication: 2024 Nov 07.